DAWN HEBERT: Open Payments
NPI 1043553993 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 41 payments from 18 companies in 2025. Trend: 2023 $1,243 · 2024 $1,864 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 11 | $260 |
| Vifor Pharma, Inc. | 5 | $102 |
| AKEBIA THERAPEUTICS INC | 3 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| NxStage Medical, Inc. | 1 | $76 |
| Alexion Pharmaceuticals, Inc. | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Amgen Inc. | 2 | $33 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VELPHORO, Veltassa, NXSTAGE SYSTEM ONE, ULTOMIRIS, Vafseo, Kerendia, Fabhalta, TAVNEOS.
Industry payments across LA — which companies pay providers there.
